about
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsAntiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsImmunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipientsEpstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.Cytomegalovirus infection in immunosuppressed patients after kidney transplantationBacterial infection after liver transplantationReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesParasitic infectionsLinalool, a Piper aduncum essential oil component, has selective activity against Trypanosoma cruzi trypomastigote forms at 4°C2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.Infection in Organ Transplantation.Long-term impact of CMV infection on allografts and on patient survival in renal transplant patients with protocol biopsies.Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.The onset of rapidly progressive neurologic deterioration after a brief gastrointestinal illness in a renal allograft recipient.A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.Cytomegalovirus: pathogen, paradigm, and puzzleThrombotic microangiopathy and hypothermia in an HIV-positive patient: importance of cytomegalovirus infection.Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis.Cytomegalovirus disease in renal transplant recipients: a single-center experienceCytomegalovirus and Aspergillus spp. coinfection in organ transplantation: a case report and review of the literatureProspective, comprehensive, and effective viral monitoring in Cuban children undergoing solid organ transplantation.Infections after living donor liver transplantation in children.New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsRenal transplantation: relationship between hospital/surgeon volume and postoperative severe sepsis/graft-failure. a nationwide population-based study.A Systematic Review and Meta-analysis of Prophylactic versus Pre-emptive Strategies for Preventing Cytomegalovirus Infection in Renal Transplant Recipients.Fungal infections in transplant and oncology patients.A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised hostApolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients.Assistance programs available for medications commonly used in transplant patients.Pediatric heart transplantation-indications and outcomes in the current era.Cadaver donor screening for infectious agents in solid organ transplantation.Early ileocolonoscopy with biopsy for the evaluation of persistent post-transplantation diarrheaShedding light on the elusive role of endothelial cells in cytomegalovirus dissemination.Antifungal pharmacodynamics: review of the literature and clinical applications.Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assaysClostridium difficile colitis in patients after kidney and pancreas-kidney transplantation.Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I.Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation.
P2860
Q24200697-079EFF88-4752-4421-8B8A-445C59B05804Q24243124-4B997450-E5FA-41D6-A1AE-C6805789986CQ24245120-367DF5ED-3A1A-4F5B-9D40-BBCC579600EFQ24798984-3DE2BD5E-D3E2-49BA-BEBB-44F14613EC5DQ26740169-46BEE380-56A6-4B8E-ADC9-581B13C9E38FQ26991438-6F1C78ED-51FA-473F-B5C8-262EF7628F40Q28080994-CC542107-745C-41C5-8BA8-923CCF0C8316Q28289593-8C9E8000-7EF0-48C0-8507-F948C838D0B2Q28817421-DE7DBBB5-A709-467A-BCF2-ECAC1E6108E2Q30151881-72C4F5D6-70E8-45A6-A3BC-F6B0DA9B4E18Q30238810-13643F92-CD74-47E9-A4EF-CCFFCA768BD5Q30278721-2B1B8819-F372-477D-810F-CFE807B5791FQ30422449-2A3D660B-CED9-4C36-A02C-F55338737726Q30453768-84E06303-C714-4148-855A-3630420E4C1EQ31110559-C140474E-DF91-4E90-94C0-FBAB29FCAE73Q33345650-22750C7E-8167-47CC-914B-290D289DA70FQ33351523-DCF03228-DE37-4682-BD93-92C51C04EFEAQ33360643-76A28977-A02B-4126-A65C-5FCC5DCE0903Q33364367-C5442FF6-2850-473C-AA98-04AD1F19AA70Q33410118-80A22F00-397B-4CC9-90EA-2AD7A4A1087AQ33628293-E8E13AFC-BB2C-4742-A912-3F9E44A0F55CQ33671565-9F4B4E6D-0B54-4BAF-90D7-8B4E12F48C9CQ33749798-E3D1824F-020C-4D3B-ABFB-9C5B58DE10BCQ33812425-D723970E-CAC1-492F-98E2-A32147F88B74Q33843873-7BA8DDD6-7A0A-4261-802E-0A6E33ADA91EQ33871850-64E9A9CD-11D5-42C7-8392-4D65B1592418Q33896940-26EBEA40-AB4C-4148-95E8-1ACDC28A32AAQ33922242-3B308915-BBA4-4E8A-B088-9328183BC85FQ33951763-14CE9AF5-D4C8-4063-852C-EAA6CF6544F3Q33967345-CFFD6A86-94ED-411F-A1C3-2FD008F91F7DQ34005716-7591520E-52DF-47F9-AAC5-508339224D93Q34048053-5355C616-99EC-488E-9FAD-EE485EA99DE6Q34052592-DED20670-9DA7-4373-B0D3-87A273268F53Q34063731-A2EB8B06-0BBF-47EA-A7BB-4F6745E7E765Q34082656-3A80F942-0688-4BA9-A589-C332A7A0B7ECQ34083129-E5EEEE3E-C46E-48B1-BC7C-CB9E840D5421Q34202805-B7318E6D-BEBB-410E-867B-6C975215C625Q34232411-AA11D1B0-7FFB-4DB9-914B-FE7B75548343Q34233146-AB796AF2-B549-4D87-A46B-5076E9DC9E02Q34243404-9B892A1B-3D7E-4FCE-8F1D-DFA5DA0A0618
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Infection in organ-transplant recipients.
@ast
Infection in organ-transplant recipients.
@en
Infection in organ-transplant recipients.
@nl
type
label
Infection in organ-transplant recipients.
@ast
Infection in organ-transplant recipients.
@en
Infection in organ-transplant recipients.
@nl
prefLabel
Infection in organ-transplant recipients.
@ast
Infection in organ-transplant recipients.
@en
Infection in organ-transplant recipients.
@nl
P1476
Infection in organ-transplant recipients.
@en
P2093
J A Fishman
P304
P356
10.1056/NEJM199806113382407
P407
P577
1998-06-01T00:00:00Z